Work

Anti-tumor activity of BH-30643, a novel macrocyclic kinase inhibitor, in EGFR -mutant lung cancer models.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.3110

Authors: Wei Deng, Dayong Zhai, Ping Jiang, Nancy Ling, Yue Hu, Zhenping Wang, Danan Li, Joshua Choi, Eugene Rui, Geoff Oxnard, Xiuning Le, Sai-Hong Ignatius Ou, J. Jean Cui

Institutions: The University of Texas MD Anderson Cancer Center, UC Irvine Chao Family Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410821013

Cites:

Cited by: 1

Related to: 10